Clinical trial
The Palliative Radiotherapy And Inflammation Study: Palliative Radiotherapy of Bone Metastasis. Classification, Inflammatory Biomarkers, and Longitudinal Clinical Follow-up
NCT02107664 is registered in ClinicalTrials.gov with Norwegian University of Science and Technology as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Palliative Radiotherapy And Inflammation Study: Palliative Radiotherapy of Bone Metastasis. Classification, Inflammatory Biomarkers, and Longitudinal Clinical Follow-up
- Lead sponsor
- Norwegian University of Science and Technology
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 31, 2013
- Completion date
- December 31, 2018
- Enrollment
- 580 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.